Search for Clinical Trial Results
Pancreatic Neuroendocrine Tumor - 45 Studies Found
Status | Study |
Recruiting |
Study Name: A Study Evaluating Lanreotide as Maintenance Therapy in Patients With Non-Resectable Duodeno-Pancreatic Neuroendocrine Tumors (REMINET) Condition: Metastatic/Locally Advanced, Non-resectable, Duodeno-pancreatic Neuroendocrine Tumours Date: 2014-09-23 Interventions:
|
Active, not recruiting |
Study Name: A Study Of The Efficacy And Safety Of Sunitinib In Patients With Advanced Well-Differentiated Pancreatic Neuroendocrine Tumors Condition: Well-differentiated Pancreatic Neuroendocrine Tumor Date: 2012-01-13 Interventions: Drug: sunitinib Sunitinib capsules will be given orally at continuous daily dosing with a starting dose |
Recruiting |
Study Name: A Biological Prospective Study in Patients With Metastatic Pancreatic NETs Treated With Everolimus Condition: Pancreatic Neuroendocrine Tumour Metastatic Date: 2014-06-17 Interventions: Drug: Everolimus 10 mg daily everolimus is a recently approved mTOR inhibitor in advanced progressing we |
Recruiting |
Study Name: Observational Study In Real Life Settings Of The Systemic Treatment Of Well Differentiated, Unresectable Or Metastatic, Progressive Pancreatic Neuroendocrine Tumors (pNET): A Study Of Morbidity And Mortality At 2 Years Condition: Pancreatic Neuroendocrine Tumor, Well Differentiated and Progressive Date: 2014-09-02 Interventions:
|
Active, not recruiting |
Study Name: Peptide Receptor Radionuclide Therapy With 177Lu-Dotatate Associated With Metronomic Capecitabine In Patients Affected By Aggressive Gastro-Etero-Pancreatic Neuroendocrine Tumors Condition:
|
Active, not recruiting |
Study Name: Clinical Effectiveness of Serum Chromogranin A Levels on Diagnostic of Pancreatic Neuroendocrine Tumors Condition: Non Functioning Pancreatic Endocrine Tumor Date: 2016-04-26 Interventions: Biological: Chromogranin A The plasma level of chromogranin A (CgA) was measured in enrolled patients wh |
Recruiting |
Study Name: Sapanisertib in Treating Patients With Metastatic or Refractory Pancreatic Neuroendocrine Tumor That Cannot Be Removed by Surgery Condition:
|
Completed |
Study Name: Comparative Study of Robotic, Laparoscopic and Open Surgery for Enucleation of Benign Pancreatic Neoplasms Condition: Pancreatic Neuroendocrine Tumors Date: 2014-04-26 Interventions:
|
Recruiting |
Study Name: Phase IV Study of the Safety and Efficacy of Everolimus in Adult Patients With Progressive pNET in China Condition: Pancreatic Neuroendocrine Tumors Date: 2016-06-16 Interventions: Drug: everolimus Everolimus is taken at a starting dose of 10 mg orally once daily.Patients will be prov |
Completed |
Study Name: An Analysis of Presentation and Outcome Following Treatment of Pancreatic Endocrine Neoplasms Condition: Pancreatic Endocrine Neoplasms Date: 2015-03-23 |